Andere Sprachen Novo Nordisk A/S

Aktien

A3EU6F

DK0062498333

NOVO B

Pharmazeutika

Markt geschlossen - Nasdaq Copenhagen Andere Börsenplätze 17:20:00 17.09.2024			% 5 Tage	% 1. Jan.
903,40 ^DKK	-2,03 %		+1,85 %	+29,41 %

17.09.	Sektor-Update: Aktien des Gesundheitswesens geben am späten Nachmittag nach	MT
17.09.	Sektor Update: Gesundheitswesen	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Health Care Down as Novo Nordisk Slides on Drug-Price Fears - Health Care Roundup	17.09.
Sector Update: Health Care Stocks Retreat Late Afternoon	17.09.
Sector Update: Health Care	17.09.
Novo Nordisk's Ozempic Likely to Face U.S. Price Negotiations, Bloomberg Reports	17.09.
US Senator Sanders says generic drugmakers could sell Ozempic for less than $100/month	17.09.
Novo Nordisk Exec Says Ozempic 'Very Likely' to Face Drug Price Negotiations	17.09.
Novo Nordisk Exec Says Ozempic 'Very Likely' to Face Drug Price Negotiations, Bloomberg Reports	17.09.
Novo Nordisk A/S - share repurchase programme	16.09.
Korro Bio Partners With Novo Nordisk to Develop Genetic Medicines	16.09.
Korro Bio, Inc Announces Collaboration with Novo Nordisk to Develop Two Therapeutic Candidates	16.09.
Eli Lilly invests $1.8 billion in Ireland sites to scale up Alzheimer's, obesity drug production	13.09.
Los datos del medicamento contra la obesidad de Novo Nordisk confirman el optimismo de los inversores -- Market Talk	12.09.
Roche shares drop on side effects result in early-stage obesity pill trial	12.09.
Health Care Down on Cyclical Bias -- Health Care Roundup	11.09.
Sector Update: Health Care Stocks Narrowly Mixed Premarket Wednesday	11.09.
Novo Nordisk's Experimental Obesity Pill Could Be More Effective With Extended Use	11.09.
Novo Nordisk Reports Positive Results of Phase 3a Trial of Anti-Obesity Drug Liraglutide in Children	11.09.
Estudio revela que fármaco contra la obesidad más antiguo de Novo es seguro y eficaz para los niños	11.09.
Weight-loss drug Saxenda effective for kids as young as 6, study shows	11.09.
Health Care Up on Defensive Bias -- Health Care Roundup	10.09.